These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19574921)

  • 1. Strategies to enhance cardiovascular disease prevention in patients with diabetes.
    Anselmino M; Rydén L
    Curr Opin Cardiol; 2009 Sep; 24(5):461-7. PubMed ID: 19574921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Goff DC; Gerstein HC; Ginsberg HN; Cushman WC; Margolis KL; Byington RP; Buse JB; Genuth S; Probstfield JL; Simons-Morton DG;
    Am J Cardiol; 2007 Jun; 99(12A):4i-20i. PubMed ID: 17599424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
    Lim HS; Blann AD; Lip GY
    Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proinflammatory and hypercoagulable state of diabetes mellitus.
    Aras R; Sowers JR; Arora R
    Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When statin therapy stops: implications for the patient.
    Daskalopoulou SS
    Curr Opin Cardiol; 2009 Sep; 24(5):454-60. PubMed ID: 19574923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
    Pöss J; Böhm M; Laufs U
    Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up.
    Jelinek M; Vale MJ; Liew D; Grigg L; Dart A; Hare DL; Best JD
    Heart Lung Circ; 2009 Dec; 18(6):388-92. PubMed ID: 19648058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of coronary artery disease.
    Hall SL; Lorenc T
    Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative management of patients undergoing non-cardiac vascular surgery.
    Howell SJ; Vohra RS
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):625-31. PubMed ID: 17888691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed dose combination therapy and CVD protection: "a need of the hour".
    Chopra HK
    Indian Heart J; 2009; 61(4):316-21. PubMed ID: 20635732
    [No Abstract]   [Full Text] [Related]  

  • 16. Trials of cardiovascular risk factor management in type 2 diabetes.
    Patel A; Joshi R; de Galan B
    Curr Opin Cardiol; 2009 Jul; 24(4):288-94. PubMed ID: 19322080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence and the patient with coronary artery disease: challenges for the practitioner.
    Maddox TM; Ho PM
    Curr Opin Cardiol; 2009 Sep; 24(5):468-72. PubMed ID: 19550308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk reduction: who needs treatment?
    Betteridge DJ
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S15-22. PubMed ID: 15885846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.